Format
Sort by
Items per page

Send to

Choose Destination

Best matches for crohn's disease glutathione:

Does active Crohn's disease have decreased intestinal antioxidant capacity? Pinto MA et al. J Crohns Colitis. (2013)

Concepts of oxidative stress and antioxidant defense in Crohn's disease. Alzoghaibi MA et al. World J Gastroenterol. (2013)

Role of N-acetylcysteine and GSH redox system on total and active MMP-2 in intestinal myofibroblasts of Crohn's disease patients. Romagnoli C et al. Int J Colorectal Dis. (2013)

Search results

Items: 1 to 20 of 111

1.

Markers of lipid peroxidation and antioxidant status in the serum and saliva of patients with active Crohn disease.

Szczeklik K, Krzyściak W, Cibor D, Domagała-Rodacka R, Pytko-Polończyk J, Mach T, Owczarek D.

Pol Arch Intern Med. 2018 Jun 30;128(6):362-370. doi: 10.20452/pamw.4273. Epub 2018 May 28.

2.

Comparison of two models of inflammatory bowel disease in rats.

Catana CS, Magdas C, Tabaran FA, Crăciun EC, Deak G, Magdaş VA, Cozma V, Gherman CM, Berindan-Neagoe I, Dumitraşcu DL.

Adv Clin Exp Med. 2018 May;27(5):599-607. doi: 10.17219/acem/69134.

3.

Epiisopiloturine, an imidazole alkaloid, reverses inflammation and lipid peroxidation parameters in the Crohn disease model induced by trinitrobenzenosulfonic acid in Wistar rats.

Rodrigues de Carvalho L, de Brito TV, Simião da C Júnior J, José Dias Júnior G, de Aguiar Magalhãres D, Guimarães Sousa S, Oliveira Silva R, Rodolfo Pereira da Silva F, Fernando Pereira Vasconcelos D, Maria Costa Véras L, de Sousa de Almeida Leite JR, Santos Martins D, da Silva Martins C, Soares de Oliveira J, Barbosa ALDR.

Biomed Pharmacother. 2018 Jun;102:278-285. doi: 10.1016/j.biopha.2018.03.090. Epub 2018 Mar 22.

PMID:
29567541
4.

Association between SOD1, CAT, GSHPX1 polymorphisms and the risk of inflammatory bowel disease in the Polish population.

Mrowicka M, Mrowicki J, Mik M, Wojtczak R, Dziki L, Dziki A, Majsterek I.

Oncotarget. 2017 Nov 27;8(65):109332-109339. doi: 10.18632/oncotarget.22675. eCollection 2017 Dec 12.

5.

Reduced Transferrin Levels in Active Inflammatory Bowel Disease.

Matusiewicz M, Neubauer K, Lewandowska P, Gamian A, Krzystek-Korpacka M.

Biomed Res Int. 2017;2017:9541370. doi: 10.1155/2017/9541370. Epub 2017 Oct 31.

6.

[Gut-liver axis in inflammatory bowel disease. A retrospective study].

Egresi A, Kovács Á, Szilvás Á, Blázovics A.

Orv Hetil. 2017 Jul;158(26):1014-1021. doi: 10.1556/650.2017.30781. Hungarian.

PMID:
28651460
7.

Association Study of Glutathione S-transferases Gene Polymorphisms (GSTM1 and GSTT1) with Ulcerative Colitis and Crohn's Disease in the South of Iran.

Moini M, Saadat M, Saadat H, Esmailnejad A, Safarpour A.

Adv Biomed Res. 2017 Jun 6;6:67. doi: 10.4103/2277-9175.190981. eCollection 2017.

8.

Urinary metabolic insights into host-gut microbial interactions in healthy and IBD children.

Martin FP, Su MM, Xie GX, Guiraud SP, Kussmann M, Godin JP, Jia W, Nydegger A.

World J Gastroenterol. 2017 May 28;23(20):3643-3654. doi: 10.3748/wjg.v23.i20.3643.

9.

Glutathione S-Transferase T1 Null Genotype is Associated with Susceptibility to Inflammatory Bowel Disease.

Qian J, Song Z, Lv Y, Huang X, Mao B.

Cell Physiol Biochem. 2017;41(6):2545-2552. doi: 10.1159/000475978. Epub 2017 May 4.

10.

Reactive oxygen species and antioxidant defense in human gastrointestinal diseases.

Patlevič P, Vašková J, Švorc P Jr, Vaško L, Švorc P.

Integr Med Res. 2016 Dec;5(4):250-258. doi: 10.1016/j.imr.2016.07.004. Epub 2016 Jul 29. Review.

11.

Boswellic Acid Improves Cognitive Function in a Rat Model Through Its Antioxidant Activity: - Neuroprotective effect of Boswellic acid.

Ebrahimpour S, Fazeli M, Mehri S, Taherianfard M, Hosseinzadeh H.

J Pharmacopuncture. 2017 Mar;20(1):10-17. doi: 10.3831/KPI.2017.20.001.

12.

Comprehensive bioinformatics analyses of Crohn's disease.

Zhou Y, Zhan C, Huang Y, Liu H.

Mol Med Rep. 2017 Apr;15(4):2267-2272. doi: 10.3892/mmr.2017.6250. Epub 2017 Feb 28.

PMID:
28260036
13.

Evaluation of Effect CAT -262C/T, SOD + 35A/C, GPx1 Pro197Leu Polymorphisms in Patients with IBD in the Polish Population.

Mrowicki J, Mrowicka M, Majsterek I, Mik M, Dziki A, Dziki Ł.

Pol Przegl Chir. 2016 Dec 1;88(6):321-327. doi: 10.1515/pjs-2016-0071.

PMID:
28141554
14.

Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel Disease.

Costa Pereira C, Durães C, Coelho R, Grácio D, Silva M, Peixoto A, Lago P, Pereira M, Catarino T, Pinho S, Teixeira JP, Macedo G, Annese V, Magro F.

PLoS One. 2017 Jan 4;12(1):e0169102. doi: 10.1371/journal.pone.0169102. eCollection 2017.

15.

Alterations in glutathione peroxidase and superoxide dismutase activities in plasma and saliva in relation to disease activity in patients with Crohn's disease.

Szczeklik K, Krzysciak W, Domagala-Rodacka R, Mach P, Darczuk D, Cibor D, Pytko-Polonczyk J, Rodacki T, Owczarek D.

J Physiol Pharmacol. 2016 Oct;67(5):709-715.

16.

Spray-dried microparticles of glutathione and S-nitrosoglutathione based on Eudragit® FS 30D polymer.

Shah SU, Socha M, Sejil C, Gibaud S.

Ann Pharm Fr. 2017 Mar;75(2):95-104. doi: 10.1016/j.pharma.2016.09.001. Epub 2016 Oct 19.

PMID:
27770996
17.

Oxidative stress due to Mycobacterium avium subspecies paratuberculosis (MAP) infection upregulates selenium-dependent GPx activity.

Qasem A, Abdel-Aty A, Abu-Suwa H, Naser SA.

Gut Pathog. 2016 Mar 2;8:12. doi: 10.1186/s13099-016-0090-8. eCollection 2016.

18.

Genetic Predictors of Azathioprine Toxicity and Clinical Response in Patients with Inflammatory Bowel Disease.

Al-Judaibi B, Schwarz UI, Huda N, Dresser GK, Gregor JC, Ponich T, Chande N, Mosli M, Kim RB.

J Popul Ther Clin Pharmacol. 2016;23(1):e26-36. Epub 2016 Feb 22.

PMID:
26950049
19.

Synthesis of S-nitrosoglutathione-alginate for prolonged delivery of nitric oxide in intestines.

Shah SU, Socha M, Fries I, Gibaud S.

Drug Deliv. 2016 Oct;23(8):2927-2935. Epub 2015 Dec 15.

PMID:
26666370
20.

Genetic Polymorphisms of Multidrug Resistance Gene-1 (MDR1/ABCB1) and Glutathione S-Transferase Gene and the Risk of Inflammatory Bowel Disease among Moroccan Patients.

Senhaji N, Kassogue Y, Fahimi M, Serbati N, Badre W, Nadifi S.

Mediators Inflamm. 2015;2015:248060. doi: 10.1155/2015/248060. Epub 2015 Oct 28.

Supplemental Content

Loading ...
Support Center